ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008

Beahrs Report Urges Mammography Continuation, Says BCDDPs Effective In Detecting Early Cancer

September 17, 1977

ASCO Honors Eight With Special Awards

May 24, 2002

NCI, NSF fund awards in nanotech training.

September 23, 2005

Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson?

December 12, 2014

More Surgical Patients Die When Nurse Caseloads Rise

November 29, 2002